RAFA.US Rafarma Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
0.0080 USD
Close of Nov 17, 2026
0.0070 0.0930
Market cap
USD 702K
P/E
-
P/B
-
ROE
3.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is RAFA.US undervalued?

Graham number

The Graham number of Rafarma Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rafarma Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Rafarma Pharmaceuticals Inc yet.

Rafarma Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rafarma Pharmaceuticals Inc

Rafarma Pharmaceuticals, Inc. engages in the development and production of medical equipment. It is also involved in the supply of equipment for hospitals and clinics. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company was incorporated in 1982 and is based in Draper, Utah. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Bioc…

Full company profile